Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAmortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashDepreciation & Amortization (CF)Free Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther financing activitiesShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Viridian Therapeutics, Inc.\DE (VRDN) Change in Acquisitions & Divestments: 2016-2024

Historic Change in Acquisitions & Divestments for Viridian Therapeutics, Inc.\DE (VRDN) over the last 8 years, with Dec 2024 value amounting to $466.9 million.

  • Viridian Therapeutics, Inc.\DE's Change in Acquisitions & Divestments fell 2.61% to $140.3 million in Q3 2025 from the same period last year, while for Sep 2025 it was $562.2 million, marking a year-over-year increase of 24.71%. This contributed to the annual value of $466.9 million for FY2024, which is 48.45% up from last year.
  • Latest data reveals that Viridian Therapeutics, Inc.\DE reported Change in Acquisitions & Divestments of $466.9 million as of FY2024, which was up 48.45% from $314.5 million recorded in FY2023.
  • Viridian Therapeutics, Inc.\DE's 5-year Change in Acquisitions & Divestments high stood at $466.9 million for FY2024, and its period low was $2.0 million during FY2020.
  • In the last 3 years, Viridian Therapeutics, Inc.\DE's Change in Acquisitions & Divestments had a median value of $314.5 million in 2023 and averaged $296.8 million.
  • In the last 5 years, Viridian Therapeutics, Inc.\DE's Change in Acquisitions & Divestments slumped by 96.72% in 2020 and then skyrocketed by 5,619.90% in 2021.
  • Over the past 5 years, Viridian Therapeutics, Inc.\DE's Change in Acquisitions & Divestments (Yearly) stood at $2.0 million in 2020, then skyrocketed by 5,619.90% to $114.4 million in 2021, then declined by 4.78% to $108.9 million in 2022, then surged by 188.73% to $314.5 million in 2023, then soared by 48.45% to $466.9 million in 2024.